Citation Impact
Citing Papers
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter
2010 StandoutNobel
Formylglycine-generating enzyme binds substrate directly at a mononuclear Cu(I) center to initiate O 2 activation
2019 StandoutNobel
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
2002
Role of Genotype in the Cycle of Violence in Maltreated Children
2002 StandoutScience
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
The DNA-damage response in human biology and disease
2009 StandoutNature
Genome-Wide siRNA-Based Functional Genomics of Pigmentation Identifies Novel Genes and Pathways That Impact Melanogenesis in Human Cells
2008
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease
2001
Effect of Buthionine Sulfoximine, a Synthesis Inhibitor of the Antioxidant Glutathione, on the Murine Nigrostriatal Neurons
1996
Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses
2018 StandoutNobel
The benefits and limitations of animal models for translational research in neurodegenerative diseases
2010
Iron, Free Radicals, and Oxidative Injury
2004
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
2002
Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases
2004
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Free radicals, metals and antioxidants in oxidative stress-induced cancer
2006 Standout
Excitotoxic Neuronal Death and the Pathogenesis of Huntington's Disease
2008
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
2003
Mitochondrial dysfunction, apoptotic cell death, and Alzheimer’s disease
2003
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Proteasomal function is impaired in substantia nigra in Parkinson's disease
2001
The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration
1999
Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter
1999
Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases
1996
Oxidative stress and the pathogenesis of Parkinson's disease
1996
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
The structure of neuromelanin as studied by chemical degradative methods
2003
Balancing Acts
2004 Standout
Protection of PC12 cells by glutathione peroxidase in L-DOPA induced cytotoxicity
1998
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
2007
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study
1996
Prefrontal and Striatal Volumes in Monozygotic Twins Concordant and Discordant for Schizophrenia
2010
Free radicals in Alzheimer’s disease
1998
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
High‐field magnetic resonance imaging of brain iron: birth of a biomarker?
2004
The Relevance of Iron in the Pathogenesis of Parkinson's Disease
2004
Advances in the molecular characterization of tryptophan hydroxylase
1998
Parkinson's disease
2015 Standout
Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death
1997
Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP111-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
2003
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Autophagy in Human Health and Disease
2013 Standout
The Potential Role of Iron Chelators in the Treatment of Parkinson's Disease and Related Neurological Disorders
1997
Rethinking schizophrenia
2010 StandoutNature
Catechol‐Based Biomimetic Functional Materials
2012
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
2000 StandoutNature
Structure/function of α‐synuclein in health and disease: rational development of animal models for Parkinson's and related diseases
2002
The Role of Iron in Neurodegeneration
1999
The relevance of iron in the pathogenesis of Parkinson’s disease
2010
Imaging Physiologic Dysfunction of Individual Hippocampal Subregions in Humans and Genetically Modified Mice
2000 StandoutNobel
Metabolism and functions of glutathione in brain
2000 Standout
Major Depressive Disorder
2008 Standout
Parkinson's Disease
1998 Standout
Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system
1995
Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells
2003
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Iron-binding characteristics of neuromelanin of the human substantia nigra
2003
Microtubule-associated Protein 1B Is a Component of Cortical Lewy Bodies and Binds α-Synuclein Filaments
2000
Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease
2003
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
The history of iron in the brain
1995
Interaction of neuromelanin and iron in substantia nigra and other areas of human brain
1996
Voltage-gated Calcium Channels Provide an Alternate Route for Iron Uptake in Neuronal Cell Cultures
2007
The Amyloid State of Proteins in Human Diseases
2012 Standout
Meta-analysis of serotonin transporter polymorphisms and affective disorders
2004
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Iron, brain ageing and neurodegenerative disorders
2004
Oxidative stress: Free radical production in neural degeneration
1994
Highly Selective Uptake and Release of Charged Molecules by pH‐Responsive Polydopamine Microcapsules
2011
Neurodegenerative diseases and oxidative stress
2004 Standout
The PI3K Pathway in Human Disease
2017 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
The associations between Parkinson’s disease and cancer: the plot thickens
2015
Oxidative stress and neurodegenerative disorders
1998
Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition
2005
Lipid peroxidation in neurodegeneration: new insights into Alzheimerʼs disease
2002
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Anemia of Chronic Disease
2005 Standout
Neuromelanin associated redox‐active iron is increased in the substantia nigra of patients with Parkinson's disease
2003
Parkinson's Disease
2003 Standout
The N-Terminal Tandem Repeat Region of Human Prion Protein Reduces Copper: Role of Tryptophan Residues
2000
In Vivo Evaluation of Brain Iron in Alzheimer Disease Using Magnetic Resonance Imaging
2000
Oxidative Stress, Accumulation of Biological 'Garbage', and Aging
2006
Neurochemistry of Parkinson's disease
2007
Nitric oxide neurotoxicity in neurodegenerative diseases
2004
Altered systemic iron metabolism in Parkinson's disease
1997
Multicopper Oxidases and Oxygenases
1996 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Copper Active Sites in Biology
2014 Standout
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
2004
Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
1995
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Huntington's disease: from pathology and genetics to potential therapies
2008
Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes
2006
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
A Permease-Oxidase Complex Involved in High-Affinity Iron Uptake in Yeast
1996 Science
Intracellular iron concentration of neurons with and without perineuronal nets
2007
HPLC Analysis of Reduced and Oxidized Coenzyme Q10 in Human Plasma
2001
Luminescent Functional Metal–Organic Frameworks
2011 Standout
Bioinspired fabrication of high performance composite membranes with ultrathin defect-free skin layer
2009
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Metal ion chelation in neurodegenerative disorders
2002
Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin
1999 StandoutNobel
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
2004 StandoutScience
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Antioxidants as treatment for neurodegenerative disorders
2002
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
UV Radiation and the Skin
2013 Standout
MONOAMINE OXIDASE: From Genes to Behavior
1999
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
NMR relaxation in tissues with weak magnetic inhomogeneities
2000
7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease
2014
Works of M. Gerlach being referenced
Potential sources of increased iron in the substantia nigra of parkinsonian patients
2006
Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis
2007
Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: Preliminary observations
1991
A novel technique for the isolation of Lewy bodies in brain
1998
Pharmacology of selegiline
1996
Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
1996
In Vitro Studies of Ferritin Iron Release and Neurotoxicity
1998
Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease
2005
Brain iron pathways and their relevance to Parkinson's disease
2001
Depression in Parkinson's disease: biogenic amines in CSF of ?de novo? patients
1996
Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease
2001
Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins
2000
Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra
1995
Altered redox state of platelet coenzyme Q 10 in Parkinson's disease
2000
The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour
2003
Impaired iron homeostasis in Parkinson’s disease
2000
Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?
1994
Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress?
1998
Influence of neuromelanin on oxidative pathways within the human substantia nigra
2002
Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin
1996
Anti-melanin antibodies are increased in sera in Parkinson's disease
2009
The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease
2004
Dopaminergic dysbalance in distinct basal ganglia neurocircuits: Implications for the pathophysiology of parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder
2006
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells
2004
Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acids.
1996
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
2001
Quantitation of 5HT3 receptors in forebrain of serotonin transporter deficient mice
2004
The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry
2005
Nitric oxide in the pathogenesis of Parkinson's disease.
1999